| INK Ultra Money Free |
Latest 10 SEC filings (by transaction date) for DRRX within the last 6 months | [?] |
![]() ![]() |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
May 18/22 | May 18/22 | Farfel Gail M | Direct Ownership | Common Stock | P - Open market or private purchase ![]() | 29,911 | $0.408 |
May 18/22 | May 17/22 | Azab Mohammad | Direct Ownership | Common Stock | P - Open market or private purchase | 1,800 | $0.421 |
May 18/22 | May 17/22 | Azab Mohammad | Direct Ownership | Common Stock | P - Open market or private purchase | 8,900 | $0.421 |
May 18/22 | May 17/22 | Azab Mohammad | Direct Ownership | Common Stock | P - Open market or private purchase | 9,300 | $0.419 |
May 18/22 | May 16/22 | Farfel Gail M | Direct Ownership | Common Stock | P - Open market or private purchase ![]() | 25,300 | $0.388 |
May 18/22 | May 16/22 | Azab Mohammad | Direct Ownership | Common Stock | P - Open market or private purchase | 10,000 | $0.377 |
May 13/22 | May 13/22 | Farfel Gail M | Direct Ownership | Common Stock | P - Open market or private purchase | 9,250 | $0.400 |
May 13/22 | May 12/22 | Farfel Gail M | Direct Ownership | Common Stock | P - Open market or private purchase | 1,500 | $0.390 |
May 13/22 | May 11/22 | Farfel Gail M | Direct Ownership | Common Stock | P - Open market or private purchase ![]() | 9,950 | $0.399 |
May 12/22 | May 10/22 | Farfel Gail M | Direct Ownership | Common Stock | P - Open market or private purchase ![]() | 2,339 | $0.406 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for DRRX within the last 6 months | [?] |
![]() ![]() |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
May 18/22 | May 18/22 | Farfel Gail M | Direct Ownership | Common Stock | P - Open market or private purchase ![]() | 29,911 | $0.408 |
May 18/22 | May 16/22 | Farfel Gail M | Direct Ownership | Common Stock | P - Open market or private purchase ![]() | 25,300 | $0.388 |
May 18/22 | May 17/22 | Azab Mohammad | Direct Ownership | Common Stock | P - Open market or private purchase | 1,800 | $0.421 |
May 18/22 | May 17/22 | Azab Mohammad | Direct Ownership | Common Stock | P - Open market or private purchase | 8,900 | $0.421 |
May 18/22 | May 17/22 | Azab Mohammad | Direct Ownership | Common Stock | P - Open market or private purchase | 9,300 | $0.419 |
May 18/22 | May 16/22 | Azab Mohammad | Direct Ownership | Common Stock | P - Open market or private purchase | 10,000 | $0.377 |
May 13/22 | May 13/22 | Farfel Gail M | Direct Ownership | Common Stock | P - Open market or private purchase | 9,250 | $0.400 |
May 13/22 | May 12/22 | Farfel Gail M | Direct Ownership | Common Stock | P - Open market or private purchase | 1,500 | $0.390 |
May 13/22 | May 11/22 | Farfel Gail M | Direct Ownership | Common Stock | P - Open market or private purchase ![]() | 9,950 | $0.399 |
May 12/22 | May 10/22 | Farfel Gail M | Direct Ownership | Common Stock | P - Open market or private purchase ![]() | 2,339 | $0.406 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Regeneron Pharmaceuticals (OQ:REGN) |
Intra-Cellular Therapies (OQ:ITCI) |
Epizyme (OQ:EPZM) |